UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Clinical trials for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized cell therapy takes on resistant cancers
Disease control OngoingThis study tests a treatment made from a patient's own immune cells (called LN-145) for cancers like ovarian, triple-negative breast, anaplastic thyroid, and bone sarcomas that have not responded to standard therapy or have returned. The cells are taken from the tumor, grown in a…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New immune combo shows promise in early sarcoma trial
Disease control OngoingThis early-stage study tests whether adding an experimental drug (BO-112) to an immunotherapy (nivolumab) before surgery is safe for people with soft tissue sarcoma that can be removed. The goal is to see if this combination can boost the immune system to better attack the cancer…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy shows promise for rare sarcomas
Disease control OngoingThis study tests whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before surgery. About 140 patients with newly diagnosed, removable tumors took part. The goal is to see if the combination is safe and improves tumor respo…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC